Market Overview:
The global hematocrit test market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of anemia, rising geriatric population, and growing demand for point-of-care testing. Hematocrit test meters are expected to account for the largest share of the global hematocrit test market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. Hospitals are expected to account for the largest share of the global hematocrit test market in 2018.
Product Definition:
A hematocrit test measures the percentage of red blood cells in a sample of blood. A high hematocrit level may indicate that you have anemia.
Hematocrit Test Meter:
Hematocrit is the percentage of RBCs in the total blood volume. It helps measure the red blood cells (RBCs) in a patient's body and is used to evaluate certain medical conditions, such as chronic anemia, leukemia, polycythemia vera ( uncontrolled high red blood cell count), and iron deficiency anemia. The hematocrit test measures the percentage of RBCs in whole blood samples taken from patients through venipuncture.
Analyzers:
An analyzers is a tool that helps in determining the concentration of hemoglobin in the blood. It works by measuring the volume percentage of oxygen carried by hemoglobin. The normal range for hematocrit is 40% to 50%.
The hematocrit test determines whether or not a patient has developed anemia caused due to chronic blood loss, infections, and other diseases.
Application Insights:
Based on the application, the market is segmented into hospitals, clinics and other. Hospitals held the largest share in 2017 owing to factors such as high usage of blood fractionation procedures and availability of advanced healthcare facilities. However, due to increasing prevalence of chronic diseases such as cardiovascular diseases and an aging population, hematocrit tests are being used in clinics & hospitals as well. As a result, both segments are expected to witness growth over the forecast period.
The others segment includes laboratories that offer hematocrit testing services outside medical settings (such as pathology laboratories). Increasing awareness about these services among individuals who have their blood analyzed for clinical trials or research at commercial diagnostic labs is expected to be a key factor driving this segment over the forecast period. Hematocrit tests are also used by physicians for making decisions regarding patient treatment during surgeries or emergency room visits based on hemoglobin levels measured from fresh frozen plasma or whole blood samples collected from patients without waiting for laboratory results.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of advanced diagnostic technologies, and favorable reimbursement policies & regulatory reforms in this region. In addition, increasing number of research activities by various universities and hematology centers is expected to drive the growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population base with low immunity levels coupled with increasing incidence rates of cancer & blood diseases such as leukemia & lymphoma that requires frequent monitoring for therapeutic interventions. Moreover, growing medical tourism industry due to lower treatment costs in emerging countries such as India and China are expected fuel regional market growth during the estimated time span from 2018 - 2030 (USD Million).
Growth Factors:
- Increasing incidence of anemia: The increasing incidence of anemia is one of the key growth drivers for the hematocrit test market. Anemia is a condition in which there is a deficiency of red blood cells or hemoglobin in the blood, resulting in reduced oxygen-carrying capacity. This can lead to fatigue, shortness of breath, and other health problems. According to the World Health Organization (WHO), an estimated 1.62 billion people were affected by anemia worldwide in 2013. This number is expected to increase to 1.84 billion by 2025 due to population growth and aging [1]. Thus, there will be a growing demand for hematocrit tests as more people are diagnosed with anemia.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases such as cancer, diabetes mellitus, and heart disease is another key driver for the hematocrit test market [2]. These diseases can cause abnormalities in red blood cell production and function, leading to an increase in the need for hematocrit testing services.. For example, cancer patients often require regular monitoring of their hemoglobin levels as chemotherapy can cause bone marrow suppression and lead to severe anemia [3]. Thus, there will be continued demand from this segment for accurate diagnostic tests such as hematocrit tests..
Scope Of The Report
Report Attributes
Report Details
Report Title
Hematocrit Test Market Research Report
By Type
Hematocrit Test Meter, Analyzers, Other
By Application
Hospitals, Clinics, Other
By Companies
Abbott, Roche, Danaher, Horiba, Siemens, Nihon Kohden, Bio-Rad Laboratories, Mindray, Boule Diagnostics, Sysmex Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Hematocrit Test Market Report Segments:
The global Hematocrit Test market is segmented on the basis of:
Types
Hematocrit Test Meter, Analyzers, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- Danaher
- Horiba
- Siemens
- Nihon Kohden
- Bio-Rad Laboratories
- Mindray
- Boule Diagnostics
- Sysmex Corporation
Highlights of The Hematocrit Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hematocrit Test Meter
- Analyzers
- Other
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hematocrit Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the major companies in the hematocrit test market are Abbott, Roche, Danaher, Horiba, Siemens, Nihon Kohden, Bio-Rad Laboratories, Mindray, Boule Diagnostics, Sysmex Corporation.
The hematocrit test market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hematocrit Test Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hematocrit Test Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hematocrit Test Market - Supply Chain
4.5. Global Hematocrit Test Market Forecast
4.5.1. Hematocrit Test Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hematocrit Test Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hematocrit Test Market Absolute $ Opportunity
5. Global Hematocrit Test Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hematocrit Test Market Size and Volume Forecast by Type
5.3.1. Hematocrit Test Meter
5.3.2. Analyzers
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hematocrit Test Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hematocrit Test Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hematocrit Test Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hematocrit Test Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hematocrit Test Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hematocrit Test Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hematocrit Test Demand Share Forecast, 2019-2026
9. North America Hematocrit Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hematocrit Test Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hematocrit Test Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hematocrit Test Market Size and Volume Forecast by Type
9.7.1. Hematocrit Test Meter
9.7.2. Analyzers
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hematocrit Test Demand Share Forecast, 2019-2026
10. Latin America Hematocrit Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hematocrit Test Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hematocrit Test Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hematocrit Test Market Size and Volume Forecast by Type
10.7.1. Hematocrit Test Meter
10.7.2. Analyzers
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hematocrit Test Demand Share Forecast, 2019-2026
11. Europe Hematocrit Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hematocrit Test Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hematocrit Test Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hematocrit Test Market Size and Volume Forecast by Type
11.7.1. Hematocrit Test Meter
11.7.2. Analyzers
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growh Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hematocrit Test Demand Share, 2019-2026
12. Asia Pacific Hematocrit Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hematocrit Test Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hematocrit Test Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hematocrit Test Market Size and Volume Forecast by Type
12.7.1. Hematocrit Test Meter
12.7.2. Analyzers
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hematocrit Test Demand Share, 2019-2026
13. Middle East & Africa Hematocrit Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hematocrit Test Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hematocrit Test Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hematocrit Test Market Size and Volume Forecast by Type
13.7.1. Hematocrit Test Meter
13.7.2. Analyzers
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hematocrit Test Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hematocrit Test Market: Market Share Analysis
14.2. Hematocrit Test Distributors and Customers
14.3. Hematocrit Test Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Horiba
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Siemens
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nihon Kohden
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bio-Rad Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mindray
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Boule Diagnostics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sysmex Corporation
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
